Most Covered Entities understand that the 340B Drug Pricing Program creates opportunities to reduce medication acquisition costs and reinvest savings into patient care. Yet many organizations are surprised to learn that they are not realizing the full financial potential of their programs.
In our experience, the issue is rarely a lack of eligible patients. Instead, it is often the result of operational inefficiencies, outdated workflows, inconsistent oversight, or missed opportunities to optimize existing processes.
At Thrive 340B, one of the first questions we ask new clients is simple:
“How do you know you’re capturing every eligible prescription?”
The answer is often, “We’re not sure.”
That uncertainty can represent hundreds of thousands—or even millions—of dollars in unrealized program savings over time.
Revenue Optimization Begins with Compliance
Some organizations think of compliance and revenue as competing priorities.
They’re not.
The strongest 340B programs understand that financial performance is built on a foundation of compliance. Accurate documentation, appropriate patient eligibility, effective pharmacy partnerships, and reliable internal controls not only reduce regulatory risk—they also improve program performance.
Organizations that consistently monitor and improve these areas often discover opportunities to increase savings without seeing a single additional patient.
Missed Eligible Prescriptions
One of the largest sources of lost revenue is simply failing to capture eligible prescriptions.
This can happen for many reasons:
- Incorrect provider mappings
- Split-billing software configuration errors
- Documentation gaps
- Registration issues
- Missing encounter information
- Incorrect location assignments
- Workflow inconsistencies
Each individual prescription may represent only a modest amount of savings, but across thousands of eligible encounters each year, the financial impact can be substantial.
Routine audits of accumulation reports and prescribing patterns can identify these missed opportunities before they become long-term revenue losses.
Provider Credentialing Matters More Than Many Organizations Realize
340B eligibility often depends on the relationship between the provider, the Covered Entity, and the patient encounter.
When provider information is incomplete or inaccurate, eligible prescriptions may never enter the accumulation process.
Examples include:
- Newly hired providers not properly linked
- Outdated credentialing information
- Incorrect clinic assignments
- Missing employment documentation
- Provider records that haven’t been updated after organizational changes
A single administrative oversight can affect thousands of prescriptions annually.
Regular reviews of provider eligibility and credentialing should be a routine component of every 340B compliance program.
Are Your Contract Pharmacies Performing?
Many Covered Entities maintain multiple contract pharmacy relationships.
However, not all pharmacies contribute equally to program success.
Questions leadership should regularly ask include:
- Which pharmacies generate the highest capture rates?
- Where are eligible prescriptions being lost?
- Are patients abandoning prescriptions?
- Are inventory replenishment processes functioning correctly?
- How quickly are claims reconciled?
- Are contract terms still aligned with organizational goals?
Performance data often reveals significant differences between pharmacy partners.
Monitoring these metrics helps organizations make informed operational decisions rather than relying on assumptions.
Optimizing Third-Party Administrator (TPA) Performance
Your third-party administrator plays a critical role in identifying eligible prescriptions, maintaining inventory records, and supporting compliance.
Yet TPAs should not operate without oversight.
Covered Entities should periodically evaluate:
- Capture rates
- Reconciliation timelines
- Error reports
- Software configuration
- Provider mapping
- Location mapping
- Data quality
- Reporting capabilities
Even small configuration adjustments can improve capture rates while strengthening compliance.
Using Data to Drive Better Decisions
Many organizations receive monthly reports from their TPA or pharmacy partners.
Far fewer transform that information into actionable business intelligence.
Executive leadership should have access to dashboards that answer questions such as:
- What are monthly program savings?
- Which providers generate the most eligible prescriptions?
- Which clinics have the strongest capture rates?
- Where are prescriptions falling out of the accumulation process?
- Which contract pharmacies are outperforming expectations?
- What compliance trends require attention?
Without meaningful reporting, organizations are managing one of their most valuable programs with limited visibility.
Revenue Isn’t Just About More Patients
Increasing patient volume is one way to grow a 340B program—but it isn’t the only way.
Many organizations improve financial performance by:
- Streamlining workflows
- Enhancing documentation
- Expanding telemedicine
- Improving patient retention
- Strengthening referral relationships
- Optimizing pharmacy performance
- Improving provider education
- Conducting regular compliance reviews
These improvements often require far less investment than opening new clinics or hiring additional providers.
The Value of an External Review
Organizations become accustomed to their own workflows over time.
An independent review provides a fresh perspective and often identifies operational blind spots that internal teams may overlook.
At Thrive 340B, our assessments examine:
- Patient eligibility processes
- Provider eligibility
- Contract pharmacy performance
- TPA configuration
- Compliance controls
- Revenue capture
- Documentation quality
- Reporting systems
- Operational efficiency
Our goal is not simply to identify problems—it is to provide practical solutions that improve both compliance and financial performance.
A Strategic View of 340B
The most successful Covered Entities no longer view 340B as a pharmacy program alone.
They recognize it as an enterprise-wide strategic initiative involving clinical operations, finance, compliance, pharmacy, executive leadership, and community outreach.
Organizations that actively monitor performance, invest in operational excellence, and continuously improve workflows are better positioned to maximize the value of their programs while remaining compliant with federal requirements.
How Thrive 340B Helps
Thrive 340B partners with Covered Entities to build stronger, more sustainable programs through:
- Revenue optimization reviews
- Operational assessments
- External compliance audits
- Contract pharmacy evaluations
- Executive dashboards
- Telemedicine expansion
- Strategic planning
- Staff education
- HRSA audit readiness
- Continuous performance improvement
We don’t believe in one-time consulting engagements. We believe in long-term partnerships that help organizations strengthen both compliance and financial performance.
Final Thoughts
Every dollar captured through a compliant and well-managed 340B program represents an opportunity to expand patient care, improve services, and strengthen your organization’s mission.
If your leadership team cannot confidently answer whether every eligible prescription is being captured, it may be time for a comprehensive program assessment.
At Thrive 340B, we help organizations uncover hidden opportunities, improve operational performance, and ensure that their 340B programs deliver the greatest possible impact—for both their organization and the patients they serve.